Provivi Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 135

Employees

  • Latest Deal Type
  • Series C2

  • Latest Deal Amount
  • $55.5M

  • Investors
  • 13

Provivi General Information

Description

Developer of insect pheromones designed to protect food supplies without toxic residues. The company's pheromones are designed to create a new foundation for safe, affordable, and sustainable crop protection, enabling farmers to protect crops in a naturally effective and sustainable way.

Contact Information

Website
www.provivi.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Agricultural Chemicals
Other Industries
Other Agriculture
Corporate Office
  • 1701 Colorado Avenue
  • Santa Monica, CA 90404
  • United States
+1 (310) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Provivi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series C2) 03-Mar-2021 $55.5M 00000 00000 Completed Generating Revenue
10. Debt - General 16-Jun-2020 0000 00000 Completed Generating Revenue
9. Debt - PPP 09-Apr-2020 00.000 00000 Completed Generating Revenue
8. Later Stage VC (Series C) 08-Oct-2019 0000 00000 00000 Completed Generating Revenue
7. Later Stage VC 19-Sep-2018 000.00 000.00 00000 Completed Generating Revenue
6. Grant 31-Aug-2019 00000 000.00 Completed Generating Revenue
5. Grant 31-Jan-2018 00000 000.00 Completed Generating Revenue
4. Debt - General 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 06-Oct-2016 $14.2M $15.2M 000.00 Completed Generating Revenue
2. Grant 15-Dec-2015 $150K $1M Completed Generating Revenue
To view Provivi’s complete valuation and funding history, request access »

Provivi Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B2 0,000,000 00.000000 00.00 00 00 00 00 0.000
Series B1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series A1 3,542,772 $0.000010 $0.17 $2.13 $2.13 1x $2.13 13.43%
Seed 2,200,000 $0.000010 $0.45 $0.45 1x $0.45 8.34%
To view Provivi’s complete cap table history, request access »

Provivi Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of insect pheromones designed to protect food supplies without toxic residues. The company's pheromones are de
Agricultural Chemicals
Santa Monica, CA
135 As of 2024
00000
00000 0000-00-00
00000000000 00000

00000

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in v
000000000000 0000000
Wigan, United Kingdom
0 As of 0000
000
0000000000 0 000

00000

, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
000000000000 0000000
Whippany, NJ
000000 As of 0000
0000000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Provivi Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Redag Crop Venture Capital-Backed Wigan, United Kingdom 0 000 0000000000 0 000
Bayer CropScience U.S. Venture Capital-Backed Whippany, NJ 000000 0000000000 0
M2i Life Sciences Private Equity-Backed Saint-Cloud, France 000 000.00 0000000 0000 000.00
BioConsortia Venture Capital-Backed Davis, CA 00 0000 000000000000 0000
Suterra Corporate Backed or Acquired Bend, OR 000 00.000 000000&0 00.000
To view Provivi’s complete competitors history, request access »

Provivi Patents

Provivi Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230000074-A1 Sprayable microencapsulated pheromones Pending 23-Feb-2021 000000000 0
EP-4297572-A1 Sprayable microencapsulated pheromones Pending 23-Feb-2021 000000000
US-20240023547-A1 Agrochemical compositions and methods of making and using the same Pending 29-Jan-2021 000000000
EP-4284172-A1 Agrochemical compositions and methods of making and using the same Pending 29-Jan-2021 00000000
EP-4157814-A1 Synthesis of pheromone derivatives via z-selective olefin metathesis Pending 01-Jun-2020 C07C67/475
To view Provivi’s complete patent history, request access »

Provivi Executive Team (12)

Name Title Board Seat Contact Info
Pedro Coelho Ph.D Co-Founder & Chief Executive Officer
Peter Meinhold Ph.D Co-Founder & Chief Technology Officer
John Kinoshita Vice President of Finance & Controller
Frances Arnold Ph.D Co-Founder, Science Advisor & Board Member
You’re viewing 4 of 12 executive team members. Get the full list »

Provivi Board Members (9)

Name Representing Role Since
Alan Boyce Self Board Member 000 0000
Frances Arnold Ph.D Provivi Co-Founder, Science Advisor & Board Member 000 0000
Ganesh Kishore Ph.D Spruce Capital Partners Board Member 000 0000
James Demetriades Kairos Ventures Board Member 000 0000
Philip Erlanger Ph.D Aliment Capital Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Provivi Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Provivi Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Vivo Capital Venture Capital Minority 000 0000 000000 0
Aliment Capital Venture Capital Minority 000 0000 000000 0
Temasek Holdings Sovereign Wealth Fund Minority 000 0000 000000 0
Tybourne Capital Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Provivi FAQs

  • When was Provivi founded?

    Provivi was founded in 2013.

  • Who is the founder of Provivi?

    Pedro Coelho Ph.D, Peter Meinhold Ph.D, Frances Arnold Ph.D, and Mary Farrow Ph.D are the founders of Provivi.

  • Who is the CEO of Provivi?

    Pedro Coelho Ph.D is the CEO of Provivi.

  • Where is Provivi headquartered?

    Provivi is headquartered in Santa Monica, CA.

  • What is the size of Provivi?

    Provivi has 135 total employees.

  • What industry is Provivi in?

    Provivi’s primary industry is Agricultural Chemicals.

  • Is Provivi a private or public company?

    Provivi is a Private company.

  • What is the current valuation of Provivi?

    The current valuation of Provivi is 00000.

  • What is Provivi’s current revenue?

    The current revenue for Provivi is 00000.

  • How much funding has Provivi raised over time?

    Provivi has raised $212M.

  • Who are Provivi’s investors?

    Bill & Melinda Gates Foundation, Vivo Capital, Aliment Capital, Temasek Holdings, and Tybourne Capital Management are 5 of 13 investors who have invested in Provivi.

  • Who are Provivi’s competitors?

    Redag Crop, Bayer CropScience U.S., M2i Life Sciences, BioConsortia, and Suterra are some of the 6 competitors of Provivi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »